| Literature DB >> 15211626 |
Emilio Di Maria1, Rossella Gulli, Silvia Begni, Alessandro De Luca, Stefano Bignotti, Augusto Pasini, Emilia Bellone, Antonio Pizzuti, Bruno Dallapiccola, Giuseppe Novelli, Franco Ajmar, Massimo Gennarelli, Paola Mandich.
Abstract
A well established model for the pathophysiology of schizophrenia postulates a role for the NMDA-mediated glutamate transmission. The human gene coding for the 2B subunit of the NMDA receptor (GRIN2B) is considered a candidate based on its selective expression in brain. To evaluate the hypothesis that GRIN2B acts as a major gene in determining susceptibility to schizophrenia, a case-control association study was performed. Five single nucleotide polymorphisms (SNPs) were genotyped in 188 Italian patients and 156 control subjects. The association study showed a marginally significant excess of homozygosity for the polymorphism located in the 3'UTR region (P = 0.04). No other difference in genotype and allele frequencies was found in schizophrenics as compared to the control series. The case-control study was also carried out on estimated haplotypes, confirming a trend for association (P = 0.04). These results suggest that GRIN2B variations might be linked with susceptibility to schizophrenia. Replication studies on larger samples are warranted to further test this hypothesis. Copyright 2004 Wiley-Liss, Inc.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15211626 DOI： 10.1002/ajmg.b.30028
Source DB: PubMed Journal: Am J Med Genet B Neuropsychiatr Genet ISSN： 1552-4841 Impact factor: 3.568